Non-steroidal anti-inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E protein

被引:15
作者
Aleong, R [1 ]
Aumont, N [1 ]
Dea, D [1 ]
Poirier, J [1 ]
机构
[1] McGill Univ, Douglas Hosp, Res Ctr, Montreal, PQ, Canada
关键词
Alzheimer's disease; aspirin; cyclooxygenase; indomethacin; rodent;
D O I
10.1046/j.1460-9568.2003.02869.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epidemiological studies have shown that use of non-steroidal anti-inflammatory drugs (NSAIDs) by the elderly is associated with a decreased relative risk and a delayed onset of Alzheimer's disease (AD). In contrast, the apolipoprotein E (apoE) gene has proven to be a risk factor for AD with apoE epsilon4 AD patients having been found to show lower levels of brain apoE. In the present study, treatment of primary rat mixed glial cell cultures with the common NSAIDs, indomethacin and aspirin, induced significant increases in extracellular apoE protein levels. Similarly, treatment of primary rat astrocyte cell cultures with aspirin and a cyclooxygenase (COX)-2-selective aspirin derivative also stimulated significant increases in apoE protein. However, astrocyte and mixed glial apoE protein levels were significantly reduced following exposure to COX-2-specific indomethacin amides and an inactive indomethacin derivative. ApoE protein modulation was observed at physiological and subphysiological concentrations well below the COX inhibition IC50 values of the NSAIDs used, suggestive of a COX-independent mechanism. In contrast to these results, indomethacin and aspirin treatment failed to induce any significant changes in apoE mRNA levels. The failure of NSAIDs to significantly alter apoE expression may have been indicative of a nontranscriptional mechanism of apoE protein induction. Consequently, NSAID-induced increases in apoE protein may enhance apoE-mediated immunosuppression and compensatory synaptic plasticity, potentially resulting in decreased AD risk and delay of disease onset.
引用
收藏
页码:1428 / 1438
页数:11
相关论文
共 87 条
[51]   Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain [J].
Pasinetti, GM ;
Aisen, PS .
NEUROSCIENCE, 1998, 87 (02) :319-324
[52]  
*PE APPL BIOS, 1997, US B PE APPL BIOS, V2
[53]  
PERLMUTTER LS, 1993, J NEUROSCI RES, V35, P346
[54]   MHC CLASS-II-POSITIVE MICROGLIA IN HUMAN BRAIN - ASSOCIATION WITH ALZHEIMER LESIONS [J].
PERLMUTTER, LS ;
SCOTT, SA ;
BARRON, E ;
CHUI, HC .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 33 (04) :549-558
[55]   THE X-RAY CRYSTAL-STRUCTURE OF THE MEMBRANE-PROTEIN PROSTAGLANDIN-H(2) SYNTHASE-1 [J].
PICOT, D ;
LOLL, PJ ;
GARAVITO, RM .
NATURE, 1994, 367 (6460) :243-249
[56]   Apolipoprotein E, synaptic plasticity and Alzheimer's disease [J].
Poirier, J ;
Minnich, A ;
Davignon, J .
ANNALS OF MEDICINE, 1995, 27 (06) :663-670
[57]   APOLIPOPROTEIN-E IN ANIMAL-MODELS OF CNS INJURY AND IN ALZHEIMERS-DISEASE [J].
POIRIER, J .
TRENDS IN NEUROSCIENCES, 1994, 17 (12) :525-530
[58]   APOLIPOPROTEIN-E POLYMORPHISM AND ALZHEIMERS-DISEASE [J].
POIRIER, J ;
DAVIGNON, J ;
BOUTHILLIER, D ;
KOGAN, S ;
BERTRAND, P ;
GAUTHIER, S .
LANCET, 1993, 342 (8873) :697-699
[59]  
Poirier J, 2002, ADV BEHAV BIOL, V51, P39
[60]   ASTROCYTIC APOLIPOPROTEIN-E MESSENGER-RNA AND GFAP MESSENGER-RNA IN HIPPOCAMPUS AFTER ENTORHINAL CORTEX LESIONING [J].
POIRIER, J ;
HESS, M ;
MAY, PC ;
FINCH, CE .
MOLECULAR BRAIN RESEARCH, 1991, 11 (02) :97-106